Andrew Lawrence Taylor
Chief Financial Officer · Orchestra BioMed Holdings, Inc.
- 2024
- Aug 28, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Lawrence Taylor files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Darren Sherman - $364K in OBIO purchases and sales in the last 12 months
- David P. Hochman - $149K in OBIO purchases and sales in the last 12 months
- Eric S. Fain - $83K in OBIO purchases and sales in the last 12 months
- Jason Aryeh - $37K in OBIO purchases and sales in the last 12 months
- RTW INVESTMENTS, LP - $132 in OBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Lawrence Taylor?
Andrew Lawrence Taylor is a corporate insider, tracked as Chief Financial Officer of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew Lawrence Taylor submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Andrew Lawrence Taylor been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales across all tracked filings.
